Accumulating evidence indicates that inflammatory mediators-including CCL2, CCL3, CCL5, CXCL1, CCL20, TNF-α, IL-6, IL-8, and TGF-β-contribute to tumor growth, metastasis, immune modulation, and therapeutic resistance. This evidence concerns the gene CCL2 and neoplasm.